24/7 Wall St. » CRL

Top Earnings Previews For The Week Ahead (CRL, CIM, NAT, RAX, AVP, GT, MET, OMC, ZNGA, A, NVDA, PCG, DVN, DE, NTAP, CMCSA, APA, DTV, WM, JWN, AMAT, DUK, HNZ, CPB)

Administrator — Sun, 12 Feb 2012 13:22:53 +0000

Earnings season is starting to slow down a bit but we will still have some sector-moving earnings reports from major companies. 24/7 Wall St. has prepared earnings previews for the following companies:

Charles River Laboratories International Inc. (NYSE: CRL); Chimera Investment Corporation (NYSE: CIM); Nordic American Tankers Ltd. (NYSE: NAT); Rackspace Hosting Inc. (NYSE: RAX); Avon Products, Inc. (NYSE: AVP); Goodyear Tire & Rubber Co. (NYSE: GT); MetLife Inc. (NYSE: MET); Omnicom Group Inc. (NYSE: OMC); Zynga Inc. (NASDAQ: ZNGA); Agilent Technologies, Inc. (NYSE: A); NVIDIA Corporation (NASDAQ: NVDA); PG&E Corp. (NYSE: PCG); Devon Energy Corporation (NYSE: DVN); Deere & Co. (NYSE: DE); NetApp, Inc. (NASDAQ: NTAP); Comcast Corporation (NASDAQ: CMCSA); Apache Corporation (NYSE: APA); DIRECTV, Inc. (NASDAQ: DTV); Waste Management, Inc. (NYSE: WM); Nordstrom Inc. (NYSE: JWN); Applied Materials Inc. (NASDAQ: AMAT); Duke Energy Corporation (NYSE: DUK); H.J. Heinz Company (NYSE: HNZ); and Campbell Soup Company (NYSE: CPB).

Earnings estimates are from Thomson Reuters and the dates may change by the companies. More detailed previews will be available each day this coming week with much more color and trading information.

MONDAY, FEB 13

Charles River Laboratories International Inc. (NYSE: CRL) $0.56 EPS

Chimera Investment Corporation (NYSE: CIM) $0.11 EPS

Nordic American Tankers Ltd. (NYSE: NAT) -$0.29 EPS… with losses expected this year, we will be watching for any dividend news after the company sold 5.5 million shares last month.

Rackspace Hosting Inc. (NYSE: RAX) $0.15 on $281 million in sales; this one still trades at close to 60-times 2012 expected earnings of $0.81 EPS.

TUESDAY, FEB 14

Avon Products, Inc. (NYSE: AVP) $0.51 EPS on $3.11 billion; a serial disappointment in shares, but turnaround investors have hopes that the bar is set extremely low. Earnings will prove if there is a value story here or just more of a value trap.

Goodyear Tire & Rubber Co. (NYSE: GT) $0.20 EPS on $5.88 billion in sales; this is still a long-term turnaround story valued at less than 7-times expected earnings.

MetLife Inc. (NYSE: MET) $1.24 EPS on $16.81 billion in revenues; shares are mid-way between the 52-week high and 52-week low.

Omnicom Group Inc. (NYSE: OMC) $0.95 EPS on $3.8 billion in sales.

Zynga Inc. (NASDAQ: ZNGA) estimates are not yet available for its first quarterly earnings report. Shares are now back over $13.00 due to the Facebook-effect on anything tied to social media.

Don’t forget about Valentine’s Day….

Filed under: 24/7 Wall St. Wire, Calendar, Earnings, The Week Tagged: A, AMAT, APA, AVP, CIM, CMCSA, CPB, CRL, DE, DTV, DUK, DVN, GT, HNZ, JWN, MET, NAT, NTAP, NVDA, OMC, PCG, RAX, WM, ZNGA

Top Analyst Upgrades & Downgrades (CRL, CSCO, GLW, EXPE, PPDI, RL, PCLN, REGN, RIMM, RPM, BID, TSO, TIVO, URI)

Administrator — Fri, 09 Sep 2011 12:06:01 +0000

These are some of this Friday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls.

Charles River Laboratories International, Inc. (NYSE: CRL) Started as Hold at Citigroup.
Cisco Systems, Inc. (NASDAQ: CSCO) Raised to Sector Perform at RBC.
Corning Inc. (NYSE: GLW) Maintained Buy but cut target to $25 at BofA/ML.
Expedia Inc. (NASDAQ: EXPE) Started as Outperform at Wedbush.
Pharmaceutical Product Development Inc. (NASDAQ: PPDI) Started as Hold at Citigroup.
Polo Ralph Lauren (NYSE: RL) named Bull of the Day at Zacks.
Priceline.com Incorporated (NASDAQ: PCLN) Started as Outperform at Wedbush.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Cut to Underperform at BofA/ML.
Research In Motion Limited (NASDAQ: RIMM) Cut to Underperform at Jefferies.
RPM International (NYSE: RPM) Raised to Neutral at Credit Suisse.
Sotheby’s Inc. (NYSE: BID) called the value stock of the day at Zacks.
Tesoro Corporation (NYSE: TSO) Cut to Sell at Goldman Sachs.
TiVo Inc. (NASDAQ: TIVO) Started as Buy at Brean Murray.
United Rentals, Inc. (NYSE: URI) Started as Outperform at Credit Suisse.

JON C. OGG

Filed under: Analyst Calls Tagged: BID, CRL, CSCO, EXPE, GLW, PCLN, PPDI, REGN, RIMM, RL, RPM, TIVO, TSO, URI

Top Analyst Upgrades & Downgrades (BIDU, CRL, CHK, CSCO, CSC, ENER, HUM, IPI, ITT, JCI, NYX, RL, WMT)

Administrator — Thu, 10 Feb 2011 13:27:11 +0000

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning.

Baidu.com (NASDAQ: BIDU) Raised to Overweight at HSBC.
Charles River Labs (NYSE: CRL) Raised to Hold at S&P Equity Research (late-Wednesday).
Chesapeake Energy Corp. (NYSE: CHK) Raised to Hold at Argus.
Cisco Systems, Inc. (NASDAQ: CSCO) Cut to Hold at Citigroup.
Computer Sciences Corporation (NYSE: CSC) Cut to Hold at S&P Equity Research (late-Wednesday).
Energy Conversion Devices, Inc. (NASDAQ: ENER) Cut to Sell at Citigroup.
Humana Inc. (NYSE: HUM) Cut to Perform at Oppenheimer.
Intrepid Potash, Inc. (NYSE: IPI) Cut to Market Perform at BMO.
ITT Corporation (NYSE: ITT) Cut to Underweight at Morgan Stanley.
Johnson Controls Inc. (NYSE: JCI) Raised to Outperform as the Bull of the Day at Zacks Investment Research.
NYSE Euronext, Inc. (NYSE: NYX) Cut removed from Conviction Buy List at Goldman Sachs; Cut to Sell at S&P Equity Research (late-Wednesday).
Polo Ralph Lauren Corp. (NYSE: RL) Raised to Neutral at BofA/ML; On Credit Suisse focus list and target raised to $150.
Wal-Mart Stores, Inc. (NYSE: WMT) Cut to Neutral at UBS.

You can join our free daily email distribution list to hear more about analyst upgrades and downgrades, top day trader and active trader alerts, dividend trends, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Filed under: Analyst Calls Tagged: BIDU, CHK, CRL, CSC, CSCO, ENER, HUM, IPI, ITT, JCI, NYX, RL, WMT

Top Day Trader Alerts (ASF, ARNA, ABK, BAC, CRL, DISH, DRYS, GENZ, GERN, HUM, OSK)

Administrator — Mon, 02 Aug 2010 13:00:00 +0000

There are many stocks on the move for day traders and active traders to pick from this Monday morning. We are watching the key moves in Administaff Inc. (NYSE: ASF), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Ambac Financial Group, Inc. (NYSE: ABK), Bank of America Corporation (NYSE: BAC), Charles River Laboratories International, Inc. (NYSE: CRL), Dish Network Corp. (NASDAQ: DISH), DryShips Inc. (NASDAQ: DRYS), Genzyme Corp. (NASDAQ: GENZ), Geron Corporation (NASDAQ: GERN), Humana Inc. (NYSE: HUM), and Oshkosh Corporation (NYSE: OSK). We have compiled news and the moves on each and added in trading color where applicable.

Administaff Inc. (NYSE: ASF) is rallying after its Q2 earnings profit fell less than the 5% expected drop at a time when revenues rose but faced higher operating costs. Shares were up about 7% in early-bird indications and now shares are trading up 9.35% at $28.50 on relatively low-volume trading. This one only trades about 210,000 shares per day on average.

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is trading lower after J.P.Morgan downgraded it on valuation to Neutral from Overweight. Shares are down 4.8% at $7.57 on almost 400,000 shares.

Ambac Financial Group, Inc. (NYSE: ABK) stood out as a pre-market gainer in the speculative names on ongoing positive and less-negative financial sector bias. Shares are up 3% at $0.86 on about 130,000 shares.

Bank of America Corporation (NYSE: BAC) is trading higher this morning in fairly active trading after Barron’s reported that the sell-off of late offers an attractive entry point despite its changes away from overdraft and late-fee charges. Shares are up just over 2.1% at $14.34 on over 1 million shares in the pre-market.

Charles River Laboratories International, Inc. (NYSE: CRL) is feeling pain after earnings fell by more than 50% on slower sales volumes, higher costs, and weak product demand. Shares are down 7.3% at $28.80 on about 10,000 shares.

Dish Network Corp. (NASDAQ: DISH) is showing up as a stand-out gainer on high pre-market volume, but the move may be a false one. There was a $20.08 print this morning on 125,562 shares and then there were two small prints at $21.35 and $21.49…. treat this one as a false move.

DryShips Inc. (NASDAQ: DRYS) is trading higher after a newsletter tout after last week’s earnings. Shares are trading up 3.3% at $4.66 on about 55,000 shares.

Genzyme Corp. (NASDAQ: GENZ) is a bull-bear tug of war… Citi downgraded shares to Hold based upon the move versus an expected premium but goes on to say that an expected price range is $74 to $77 for a bid. Still, no formal deal has come. Shares were up 0.6% at $70.00 on about 30,000 shares.

Geron Corporation (NASDAQ: GERN) is up again after the same news drove it on Friday about the FDA clearing it to resume a stem cell study. Shares went to $5.63 on Friday versus a $4.80 close on Thursday… a gain of 17%. This morning we have shares trading up almost 6% more at $5.96 on over 150,000 shares in the pre-market.

Humana Inc. (NYSE: HUM) reported Q2 earnings of $2.00 EPS on headline numbers versus estimates of $1.67 EPS from Thomson Reuters; revenue rose almost 10% to $8.65 billion versus $8.6 billion expected.

Oshkosh Corporation (NYSE: OSK) reported $2.31 EPS vs $1.92 estimates from Thomson Reuters; revenues were basically up 100% at $2.43 billion vs. $2.29 billion expected. Shares are up almost 5% around $36.00 but trading volume is still thin on the NYSE-listed company.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Filed under: Pre-Market Activity, Trading Alert Tagged: ABK, ARNA, ASF, BAC, CRL, DISH, DRYS, GENZ, GERN, HUM, OSK

Top Day Trader Alerts (ABK, AONE, BP, CRL, WX, DEPO, DG, SOL)

Administrator — Tue, 08 Jun 2010 13:16:24 +0000

We have many stocks on the move this morning, very few tied to earnings. Tuesday’s top day trader and active trader alerts are in Ambac Financial Group, Inc. (NYSE: ABK), A123 Systems, Inc. (NASDAQ: AONE), BP plc (NYSE: BP), Charles River Laboratories International, Inc. (NYSE: CRL), WuXi PharmaTech (Cayman) Inc. (NYSE: WX), Depomed, Inc. (NASDAQ: DEPO), Dollar General Corp. (NYSE: DG), and ReneSola Ltd. (NYSE: SOL). We have added in the news, the moves, and added in color and historic prices where applicable.

Ambac Financial Group, Inc. (NYSE: ABK) is soaring this morning on news that it has converted all of its remaining $16.4 billion of exposure to a group of CDOs of asset backed securities. Shares closed at $1.03 yesterday and the stock is indicated up at $1.23 for an almost 20% gain on about 500,000 shares in pre-market trading.

A123 Systems, Inc. (NASDAQ: AONE) is recovering about half of yesterday’s gains on a further pact announcement with Navistar. Shares are up 4.4% at $8.36 on fairly thin volume this morning.

BP plc (NYSE: BP) is trying to have one day of back to business, but its shares are indicated lower. The company and ConocoPhillips (NYSE: COP) announced that the FERC has approved the venture plan to solicit interest in a $35 billion proposed natural gas pipeline between Alaska and Alberta in Canada. BP has also said that it will make an immediate payment of $60 million to Louisiana, which appears to be the first of six installments. ADRs are trading down 1.5% at $36.20 on close to 1 million shares in pre-market trading.

Charles River Laboratories International, Inc. (NYSE: CRL) and WuXi PharmaTech (Cayman) Inc. (NYSE: WX) have a challenge to the proposed merger. Jana Partners has bought 4.7 million shares for about a 7% stake in Charles River and it said that it intends to vote against the Charles River planned $1.6 billion acquisition of WuXi. Volume is thin on this, but WuXi shares are indicated down around $17.00 after a $17.75 close and Charles River shares are indicated up over $33.00 versus a $32.44 close.

Depomed, Inc. (NASDAQ: DEPO) is trading up after it announced that the FDA has accepted its New Drug Application for its investigational postherpetic neuralgia treatment DM-1796. This also triggers a milestone payment. Shares are up around $3.30 after a $3.03 close and we have seen almost 70,000 shares trade. The 52-week range is $2.32 to $6.40 and the average volume is close to 350K shares per day.

Dollar General Corp. (NYSE: DG) is up after it beat earnings expectations and raised its guidance. The stock closed at $28.23 Monday and shares are indicated up around $30.50 versus a post-IPO trading range of $21.30 to $31.41.

ReneSola Ltd. (NYSE: SOL) is trading down after filing to sell some $200 million in stock (ADS) from time to time. The market cap here was only $463 million as of yesterday’s closing bell. Shares are down 2% at $5.26 versus a 52-week range of $3.50 to $8.75.

JON C. OGG

Sponsor: 5 best investments for 2010 – The next nine months represent a bold new era for investors.

Filed under: Pre-Market Activity, Trading Alert Tagged: AONE, BP, CRL, DEPO, DG, SOL, WX

BioHealth Business Daily (CRL, DNDN, NEXM, RPC, TEVA, VVUS)

Administrator — Tue, 27 Apr 2010 18:57:13 +0000

Earnings season has taken out some of the sting from biotech and biohealth trading reactions. Today’s version of the BioHealth Business Daily is showing news and moves seen in Charles River Laboratories International, Inc. (NYSE: CRL), Dendreon Corporation (NASDAQ: DNDN), NexMed, Inc. (NASDAQ: NEXM), Radient Pharmaceuticals Corporation (AMEX: RPC), Teva Pharmaceutical Industries Limited (NASDAQ: TEVA), and VIVUS, Inc. (NASDAQ: VVUS).

Charles River Laboratories International, Inc. (NYSE: CRL) is up for a day-two reaction to its planned acquisition of WuXi. But shares are also from highs today after Moody’s said that it may downgrade Charles River on the deal. Shares are up 0.8% at $33.83 on over 3.4 million shares.

Dendreon Corporation (NASDAQ: DNDN) is one where gave a full stock, options, and short-selling review of over at BioHealthInvestor.com ahead of its pending FDA decision.

NexMed, Inc. (NASDAQ: NEXM) is today’s biggest gainer with volume in the BioHealth space. The company last night announced that the FDA has cleared it to go ahead with the proposed Phase 2 trial of PrevOnco as its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (liver cancer). Shares are up over 32% at $0.53 on over 26 million shares of volume.

Radient Pharmaceuticals Corporation (AMEX: RPC) is a rather unusual mover on the surface, although it may even be too small to bother caring about. Radient said on Monday that it had created a Medical Advisory Board and added a Director of Oncology to lead its efficacy efforts to help RPC more aggressively accelerate market awareness and adoption for the company’s Onko-Sure IVD cancer test. The market’s reaction is that things are moving too slow. Shares are down over 14% at $0.92 on about 2.2 million shares. The 52-week range is $0.20 to $2.59 and the average volume is 2.4 million shares.

Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) turns out to not be quite as perfect as all of those 52-week highs might have led everyone to believe. But they are also not indicative of a mess, as many biotech and drug operations have quality control issues throughout product and corporate life cycles. Teva’s Parenteral Medicines business unit was given an FDA warning on its manufacturing after it failed to correct manufacturing problems at the Irvine, California manufacturing facility over issues regarding contamination in batches of an anesthetic. Shares are down 1.1% at $60.20 on 4 million shares, which is not indicative of a price change nor of trading volume that any significant blow-ups are looming.

VIVUS, Inc. (NASDAQ: VVUS) is having a very good day with shares up 7% at $9.44 on almost 5 million shares (over twice-normal volume). This stock was started with a Buy rating and a $15 target at Brean Murray.

JON C. OGG

Filed under: Biotech, Drug companies, Pharmaceuticals, Trading Alert Tagged: CRL, DNDN, NEXM, RPC, TEVA, VVUS

Top 10 Analyst Upgrades, Downgrades, Initiations (ADBE, ARIA, BX, CMO, CRL, GPS, RHT, RSH, VECO, VRSN)

247wallst — Mon, 09 Nov 2009 12:56:28 +0000

These are this Monday’s top ten analyst calls with upgrades, downgrades, and initiations in Wall Street research calls:

Adobe Systems (NASDAQ: ADBE) Raised to Buy at Goldman Sachs.
Ariad Pharmaceuticals (NASDAQ: ARIA) Raised to Overweight at JP Morgan.
Blackstone Group (NYSE: BX) Raised to Outperform at KBW.
Charles River Labs (CRL) Cut to Equal Weight at Barclays.
Gap Inc. (GPS) Cut to Equal Weight at Barclays.
Red Hat (NYSE: RHT) Cut to Neutral at Goldman Sachs.
Capstead Mortgage (NYSE: CMO) Raised to Outperform at KBW.
RadioShack (NYSE: RSH) Raised to Outperform at Credit Suisse.
Veeco Instruments Inc. (NASDAQ: VECO) Started as Overweight at Piper Jaffray.
VeriSign (NASDAQ: VRSN) Cut to Sell at Goldman Sachs.

You can join our open email distribution list to get updates on top analyst upgrades and downgrades, top day trader alerts, IPO’s, secondary offerings, Warren Buffett and other guru activity, M&A and more.

Jon C. Ogg
November 9, 2009

Posted in Analyst Calls Tagged: ADBE, ARIA, BX, CMO, CRL, GPS, RHT, RSH, VECO, VRSN

The 52-Week Low Club (VCI)(SVR)(MDR)(ANN)(CRL)(GT)(NOBL)(THQI)

247wallst — Thu, 06 Nov 2008 15:49:15 +0000

Valassis Communications (VCI) Q3 loss and outlook cut. Plunges to $1.78 from 52-week high of $16.80.

Syniverse (SVR) Baird downgrades shares. Falls to $9.79 from 52-week high of $22.93.

McDermott International (MDR) Lower profit. Downgrades from Jefferies and Credit Suisse. Daily double. Off to $10.26 from 52-week high of $67.14.

Ann Taylor Stores (ANN) Grim outlook on sales. Sells down to $8.74 from 52-week high of $33.28.

Charles River Labs (CRL) Sharp cut in profit outlook. Hammered to $25.65 from 52-week high of $69.19.

Goodyear Tire & Rubber (GT) No major news. Sells off to $7.19 from 52-week high of $30.10.

Noble (NOBL) Bad quarter and Janney Mntgmy Scott downgrade. Falls to $.72 from 52-week high of $19.02.

THQ Inc (THQI) Bad numbers and downgrades by Wedbush Morgan, Kaufman, Citi, and Janco Partners. Plummets to $4.37 from 52-week high of $29.94.

Douglas A. McIntyre

Posted in HI/LOW Tagged: ANN, CRL, GT, MDR, NOBL, SVR, THQI, VCI

Top Pre-Market Analyst Downgrades (EYE, CRL, LLY, ESLR, INTC, SPWRA)

247wallst — Fri, 10 Oct 2008 07:05:14 +0000

These are some of the top pre-market analyst downgrades we are seeing this Friday morning:

Advanced Medical Optics (EYE) Cut to Underperform at Jefferies.
Charles River (CRL) Cut to Market Perform at William Blair.
Eli Lilly (LLY) Cut to Neutral at Credit Suisse.
Evergreen Solar (ESLR) Cut to Reduce at Calyon.
Intel (INTC) Cut to Sell from Buy at ThinkPanmure.
SunPower (SPWRA) Cut to Add at Calyon.

Jon C. Ogg
October 10, 2008

Posted in Analyst Calls Tagged: CRL, ESLR, EYE, INTC, LLY, SPWRA

Top 10 Pre-Market Analyst Calls (ADBE, CRL, GEOY, NOKU, HUN, IVGN, LRCX, NVO, RTN, YHOO)

247wallst — Tue, 24 Jun 2008 06:43:02 +0000

These are not all of the calls we are seeing in pre-market coverage, but these are ten of the calls impacting shares this Tuesday morning:

Adobe (NASDAQ: ADBE) raised to Overweight from Equal Weight at Morgan Stanley.
Charles River Laboratories (NYSE: CRL) downgraded to Neutral at Goldman Sachs.
GeoEye (NASDAQ: GEOY) started as Overweight at JPMorgan.
Hoku Scientific (NASDAQ: HOKU) downgraded to Neutral from Buy at Broadpoint.
Huntsman (NASDAQ: HUN) raised to Buy from Neutral at UBS.
Invitrogen (NASDAQ: IVGN) Raised to Overweight from Neutral at JPMorgan.
Lam Research (NASDAQ: LRCX) raised to Goldman Sachs Conviction Buy List from Sell at Goldman Sachs.
Novo Nordisk (NYSE: NVO) Raised to Buy from Neutral at Goldman Sachs.
Raytheon (NYSE: RTN) Raised to Overweight from Neutral at JPMorgan.
Yahoo! (NASDAQ: YHOO) Downgraded to Underweight from Market Weight at Thomas Weisel.

Elsewhere in analyst coverage, you can see the full medical & biotech calls at BioHealthInvestor.com and earlier we covered some more exclusive analyst calls in Telecom, Media & Tech as well as Credit Suisse initiating coverage on the Homebuilder sector.
Jon C. Ogg
June 24, 2008